After taking a simple saliva sample, the company analyzes DNA to provide customers with personalized genetic information on ancestry, the risk of getting specific diseases and likely response to drugs.
[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":238024,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"entrepreneur,","session":"D"}']Last week, 23andMe released a list of what it identified as top genetic findings last year. Among other findings, the company highlighted research recognizing that body shape, or body fat distribution, is influenced by genetics. The findings could have implications for 23andMe customers because body fat distribution has an affect on risk of certain diseases.
Founded in 2006, 23andMe is based in Mountain View, Calif. and has now raised nearly $54 million in funding to date.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn More